Maghinay, Maggie Franchesca I.
HRN: 20-79-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2022
CEFUROXIME 750MG (VIAL)
06/19/2022
06/19/2022
IVTT
375mg
Q8
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes